
Allistair Abraham MD
Assistant Professor, Pediatrics, George Washington University Sch of
Join to view full profile
111 Michigan Ave NwWashington, DC 20010
Phone+1 202-476-6690
Join Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 2 invites waiting! - Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Allistair Abraham, MD is a pediatric hematologist/oncologist in Washington, District of Columbia. He is currently licensed to practice medicine in District of Columbia and Virginia. He is an Assistant Professor at George Washington University Sch of.
Education & Training
University of TennesseeFellowship, Pediatric Hematology/Oncology, 2008 - 2011
University of Miami/Jackson Health SystemResidency, Pediatrics, 2005 - 2008
Georgetown University School of MedicineClass of 2005
Certifications & Licensure
DC State Medical License 2012 - 2022
VA State Medical License 2012 - 2022
Publications & Presentations
PubMed
- 24 citationsHaploidentical Bone Marrow Transplantation for Sickle Cell Disease.Adetola A Kassim, Mark C Walters, Mary Eapen, Madoc Smith, Brent R Logan
NEJM Evidence. 2025-03-01 - 6 citationsThe role of the conditioning regimen for autologous and ex vivo genetically modified hematopoietic stem cell-based therapies: recommendations from the ISCT stem cell e...Joseph H Oved, Athena Russell, Amy DeZern, Susan E Prockop, Carmem Bonfim
Cytotherapy. 2025-01-01 - 8 citationsInternational Society for Cell & Gene Therapy Stem Cell Engineering Committee report on the current state of hematopoietic stem and progenitor cell-based genomic thera...Ashish O Gupta, Melissa Azul, Senthil Velan Bhoopalan, Allistair Abraham, Alice Bertaina
Cytotherapy. 2024-11-01
Press Mentions
New Clinical Trial Gives Hope to Sickle Cell PatientsSeptember 25th, 2019
Nobel Laureate Dr. Jennifer Doudna Highlights the Future of Gene Therapy for Sickle Cell Disease at Children’s NationalApril 30th, 2026
Chemotherapy-Free Transplant Approach Offers New Hope for Children with Sickle Cell DiseaseJuly 23rd, 2026









